CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleLevered free cash flow is $35.82M, above the global median of $18.73M
- PositionGross margin is 3.3%, lower than 95% of its Medical Instruments & Supplies peers (median 44.7%)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.55BCNY678.51M · vs all stocks (USD)
Revenue (TTM)
388.90MCNY58.03M · vs all stocks (USD)
Profit Margin
-24.62%vs Medical Instruments & Supplies peers
Beta
0.7360xvs all stocks
52-Week Change
-46.22%vs all stocks
Market Capitalization
4.55BCNY678.51M · vs all stocks (USD)
Enterprise Value
4.89BCNY730.23M · vs all stocks (USD)
Forward P/E
10.62xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
11.69xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
10.53xvs Medical Instruments & Supplies peers
Enterprise to Revenue
12.58xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
-64.39xvs Medical Instruments & Supplies peers
Gross Margin
3.30%vs Medical Instruments & Supplies peers
Profit Margin
-24.62%vs Medical Instruments & Supplies peers
Operating Margin
-40.27%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-3.90%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-18.97%vs Medical Instruments & Supplies peers
Revenue (TTM)
388.90MCNY58.03M · vs all stocks (USD)
Revenue per Share (TTM)
0.7030CNYUpdated Sep 20, 2026Quarterly Revenue Growth
-32.20%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
67.61MCNY10.09M · vs all stocks (USD)
EBITDA (TTM)
-76.00MCNY-11.34M · vs all stocks (USD)
Net Income (TTM)
-95.76MCNY-14.29M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-45.05%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
207.98MCNY31.03M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
240.06MCNY35.82M · vs all stocks (USD)
5-Year Average Dividend Yield
0.22%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
17.65MCNYFY2025 · Dec 31, 2025Revenue
413.76MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
305.43MCNYFY2025 · Dec 31, 2025Gross Profit
108.33MCNYFY2025 · Dec 31, 2025Operating Income
-43.18MCNY-6.44M · vs all stocks (USD)
Pre-tax Income
-79.76MCNYFY2025 · Dec 31, 2025Income Tax Expense
2.11MCNYFY2025 · Dec 31, 2025Net Income
-81.87MCNYFY2025 · Dec 31, 2025EBIT
-61.55MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-27.69MCNYFY2025 · Dec 31, 2025Research & Development
22.51MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
22.96MCNYFY2025 · Dec 31, 2025Other Operating Expenses
2.88MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
470.20KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
18.21MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.1300CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.1300CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
640.11MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
640.11MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-81.87MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-1.34MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
90.00MCNYFY2025 · Dec 31, 2025Free Cash Flow
80.22MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
357.72MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-81.87MCNYFY2025 · Dec 31, 2025Other Non-cash Items
20.31MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
148.75MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
2.81MCNYFY2025 · Dec 31, 2025Capital Expenditures
-9.78MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-9.78MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.19BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.26BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-16.86MCNYFY2025 · Dec 31, 2025Other Financing Charges
-6.63MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-87.37MCNYFY2025 · Dec 31, 2025Shares Outstanding
658.99MSharesUpdated Sep 20, 2026Float Shares
482.30MSharesUpdated Sep 20, 2026% Held by Insiders
35.40%vs all stocks
% Held by Institutions
2.09%vs all stocks
Total Cash (MRQ)
143.30MCNY21.38M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.2170CNYUpdated Sep 20, 2026Total Debt (MRQ)
481.32MCNY71.82M · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.09xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.47xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
0.6550CNYUpdated Sep 20, 2026Total Assets
1.11BCNY166.04M · vs all stocks (USD)
Total Current Assets
977.87MCNYFY2025 · Dec 31, 2025Total Liabilities
641.73MCNYFY2025 · Dec 31, 2025Total Non-current Assets
134.88MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
5.86MCNYFY2025 · Dec 31, 2025Total Current Liabilities
635.87MCNYFY2025 · Dec 31, 2025Cash
335.71MCNYFY2025 · Dec 31, 2025Cash Equivalents
40.96MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
376.67MCNYFY2025 · Dec 31, 2025Accounts Receivable
334.38MCNYFY2025 · Dec 31, 2025Inventory
1.62MCNYFY2025 · Dec 31, 2025Accounts Payable
18.29MCNYFY2025 · Dec 31, 2025Short-term Debt
520.91MCNYFY2025 · Dec 31, 2025Other Current Liabilities
3.19MCNYFY2025 · Dec 31, 2025Long-term Debt
427.23KCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
5.34MCNYFY2025 · Dec 31, 2025Common Stock (Book)
658.99MCNYFY2025 · Dec 31, 2025Retained Earnings
-2.09BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
471.02MCNY70.29M · vs all stocks (USD)
52-Week Low
5.56CNYUpdated Sep 20, 202652-Week High
12.84CNYUpdated Sep 20, 202652-Week Change
-46.22%vs all stocks
Beta
0.7360xvs all stocks
50-Day MA
6.41CNYUpdated Sep 20, 2026200-Day MA
8.75CNYUpdated Sep 20, 2026Avg 10-Day Volume
62.26MSharesUpdated Sep 20, 2026Avg 30-Day Volume
36.63MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
-0.1500CNYUpdated Sep 20, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 3.3%, lower than 95% of its Medical Instruments & Supplies peers (median 44.7%)Significant
Gross margin: 0.03Industry median: 0.45Industry P5: 0.18Peers compared: 62.00
Operating margin is -40.3%, lower than 95% of its Medical Instruments & Supplies peers (median 11.9%)Significant
Operating margin: -0.40Industry median: 0.12Industry P5: -0.14Peers compared: 62.00
Profit margin is -24.6%, lower than 95% of its Medical Instruments & Supplies peers (median 8.7%)Significant
Profit margin: -0.25Industry median: 0.09Industry P5: -0.21Peers compared: 62.00
Financial Health
Altman Z-Score 2.18: grey zoneSignificant
Altman Z-Score: 2.18
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Levered free cash flow is $35.82M, above the global median of $18.73MNotable
Levered free cash flow (USD): 35,821,433.272Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Yamaichi Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Allied Circuit Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Beijing Sinohytec Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Longyan Zhuoyue New Energy Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Nanjing Railway New Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Sk Discovery Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Guangzhou Hi-Target Navigation Tech Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Wencan Group Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hangzhou Huawang New Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Zhejiang Tion Vanly Technology Co Ltd
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Kinross Gold Corporation
2 interpretationsFCF Ratios ElevatedCash-Flow Ratios Elevated
Keros Therapeutics Inc.
2 interpretationsFCF Ratios ElevatedCash-Flow Ratios Elevated
Haoxiangni Health Food Co., Ltd.
2 interpretationsFCF Ratios ElevatedCash-Flow Ratios Elevated